Reshape Lifesciences Stock (NASDAQ: RSLS) stock price, news, charts, stock research, profile.
Open | $0.20 |
Close | $0.19 |
Volume / Avg. | 210.61K / 5.62M |
Day Range | 0.19 - 0.20 |
52 Wk Range | 0.14 - 1.66 |
Market Cap | $4.48M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 1.08% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Reshape Lifesciences (NASDAQ:RSLS) through any online brokerage.
Other companies in Reshape Lifesciences’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Nexalin Technology (NASDAQ:NXL) and Venus Concept (NASDAQ:VERO).
There is no analysis for Reshape Lifesciences.
Reshape Lifesciences has a consensus price target of $6.33.
The stock price for Reshape Lifesciences (NASDAQ: RSLS) is $0.1911 last updated July 2, 2024 at 7:58 PM EDT.
There are no upcoming dividends for Reshape Lifesciences.
Reshape Lifesciences’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Reshape Lifesciences.
Reshape Lifesciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.